ReviewFrontiers in endocrinology2025
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance.
Patricio H Contreras et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it